Blood Cancer Charity-funded

Blood Cancer UK

Research funded by Blood Cancer UK

Funded awards
454
Published funding
Not disclosed
Active funded awards
0

Blood Cancer UK does not publish award amounts in the source data.

Search funded awards from Blood Cancer UK →

Blood Cancer UK funds most in Cancer — 303 grants (67%). Its largest recipient is University of Birmingham, with 38 grants.

Funded Awards by Year

View data table
YearFunded awards
20061
20077
200824
200931
201039
201153
201250
201358
201445
201540
201622
201721
20189
201912
20209
202120
202210
20233

Grants

A consensus definition of molecular high grade lymphoma for clinical and trial useUniversity of LeedsBCUKNot disclosed2020Completed
A Meta-analysis of SARS-CoV-2 vaccine immune responses in patients with haematological malignancies (MesSAge)University of SouthamptonBCUKNot disclosed2021Completed
A randomised phase 2 study of ASTX727 versus best supportive care in MDS/MPN Overlap Syndromes (AMMO)University of BirminghamBCUKNot disclosed2021Completed
B cell reprogramming and the route to lymphoma: 3D genome rewiring by Epstein-Barr virus.University of SussexBCUKNot disclosed2020Completed
CML-Co-vax: Seroprotection against SARS-CoV-2 in CML patients receiving TKI therapyImperial College Healthcare NHS TrustBCUKNot disclosed2021Completed
COV-VACC Immune responses to SARS-COV-2 vaccination in patients with B cell malignanciesUniversity College LondonBCUKNot disclosed2021Completed
COVID-19 vaccination responses in patients with aplastic anaemia and paroxysmal nocturnal haemoglobulinaemiaAssociated with University of Leeds · University of ManchesterBCUKNot disclosed2021Completed
COVID-19 vaccine responses in follicular lymphoma: impact of frontline therapy optionsUniversity of LiverpoolBCUKNot disclosed2021Completed
COVID19 – National COVID cancer antibody surveyAssociated with University of Aberdeen · University of BirminghamBCUKNot disclosed2021Completed
COVID19: shielding and mortality for patients with blood cancerAssociated with King's College London · University of BirminghamBCUKNot disclosed2020Completed
Deciphering Leukaemogenic Mechanisms by Integrated Systems-Scale AnalysisUniversity of CambridgeBCUKNot disclosed2019Completed
Dissecting Leukemic Stem Cell Bone Marrow Niches.The Francis Crick InstituteBCUKNot disclosed2022Completed
Dissecting the biology and therapeutic opportunities of cell states associated with treatment resistance in BCP-ALLUniversity College LondonBCUKNot disclosed2022Completed
Elucidating the mechanisms that regulate FOXO activity in chronic lymphocytic leukaemia – a novel target for therapeutic exploitation?University of GlasgowBCUKNot disclosed2019Completed
Eradication of the leukaemic clone in myeloproliferative neoplasmsUniversity of ManchesterBCUKNot disclosed2019Completed
Exploring NOX2 as a component of multi-target therapy for acute myeloid leukaemiaCardiff UniversityBCUKNot disclosed2022Completed
Harnessing Big Data to Drive Precision Medicine in Acute Lymphoblastic LeukaemiaNewcastle UniversityBCUKNot disclosed2022Completed
Hitting back at double/triple-hit lymphoma: modelling mechanisms of therapy resistanceThe Francis Crick InstituteBCUKNot disclosed2023Completed
HMRN - Cancer Research UK & Blood Cancer UK joint awardUniversity of YorkBCUKNot disclosed2020Completed
How does adiposity control myeloma dormancy to promote disease progression and relapse?University of OxfordBCUKNot disclosed2022Completed

Page 1 of 3